RESEARCH TRIANGLE PARK, N.C., Sept. 19, 2023 -- Pappas Capital, a leading investor in next-generation life science and technology companies, announced today that Nick Pappas (no relation) has joined the firm as...
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Salt Lake City, UT
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.